Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

THANK YOU

Thank you for signing-up for an online portal account

You will receive a confirmation email to the email address you've provided. A Customer Service Representative should be in touch within 2 business days with your login information. If there was a mistake in your submission, would like to provide additional information, or if you need to place an order immediately, please contact us at (866) 662-6897 or by email.